Results 251 to 260 of about 1,511,239 (338)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

ANALYSIS OF EU REGULATION OF MARKET ADMISSION OF NON-REPORTING MOBILE EQUIPMENT

open access: yesTechnical and technological aspects of development and testing of new machinery and technologies for agriculture in Ukra
Summary This article presents a comprehensive analysis and generalization of the EU’s regulatory framework regarding the market access of non-road mobile machinery (NRMM).The research objective was to study and systematize current European legislative acts, directives, and regulations, particularly the new Regulation (EU) 2025/14, which governs the ...
openaire   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Non accession of parents of children with autism spectrum disorder in music therapy: an experience report

open access: green, 2018
Abner Davi Barbosa   +3 more
openalex   +1 more source

Non Metallic Anterior Chamber Foreign Body: A Case Report

open access: hybrid
Nabilah Afifah   +2 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Examining the underreporting of social determinants of health in randomized controlled trials published in spine journals. [PDF]

open access: yesArch Orthop Trauma Surg
Megafu MN   +9 more
europepmc   +1 more source

Amino acid variation in the non-structural genes of CHKIV study isolates compared with the reference strain and previously reported sequences from Pakistan.

open access: green
Massab Umair (3159750)   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy